Mann Brenda 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Dec 8, 2020
Insider Transaction Report
Form 4
Mann Brenda
VP of Research & Development
Transactions
- Tax Payment
Common Stock
2020-12-07$3.76/sh−91$342→ 17,371 total
Footnotes (1)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 12/01/2020.